本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Design Therapeutics, Inc.

7.43
+0.06000.81%
盘后7.430.00000.00%16:10 EST
成交量:16.23万
成交额:121.53万
市值:4.23亿
市盈率:-6.26
高:7.73
开:7.47
低:7.24
收:7.37
52周最高:7.93
52周最低:2.60
股本:5,696.38万
流通股本:2,627.76万
量比:0.18
换手率:0.62%
股息:- -
股息率:- -
每股收益(TTM):-1.1872
每股收益(LYR):-0.8763
净资产收益率:-29.83%
总资产收益率:-20.59%
市净率:2.12
市盈率(LYR):-8.48

数据加载中...

2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/04

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/20

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/09/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/17

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/06/07

重要事件披露

8-K - Current report
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/23

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/23

SEC问询函

CORRESP [Cover] - Correspondence